FBIOP
Price
$16.86
Change
+$0.80 (+4.98%)
Updated
Oct 2, 04:32 PM (EDT)
Capitalization
N/A
Intraday BUY SELL Signals
VNDA
Price
$4.63
Change
-$0.18 (-3.74%)
Updated
Oct 2 closing price
Capitalization
312.59M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FBIOP vs VNDA

FBIOP vs VNDA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FBIOP vs. VNDA commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Hold and VNDA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
FBIOP vs VNDA: Fundamental Ratings
FBIOP
VNDA
OUTLOOK RATING
1..100
5817
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4676
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
5049

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIOP's Valuation (1) in the null industry is significantly better than the same rating for VNDA (91) in the Biotechnology industry. This means that FBIOP’s stock grew significantly faster than VNDA’s over the last 12 months.

FBIOP's Profit vs Risk Rating (100) in the null industry is in the same range as VNDA (100) in the Biotechnology industry. This means that FBIOP’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (98) in the Biotechnology industry is in the same range as FBIOP (100) in the null industry. This means that VNDA’s stock grew similarly to FBIOP’s over the last 12 months.

FBIOP's Price Growth Rating (46) in the null industry is in the same range as VNDA (76) in the Biotechnology industry. This means that FBIOP’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for FBIOP (100) in the null industry. This means that VNDA’s stock grew significantly faster than FBIOP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (FBIOP: $16.06 vs. VNDA: $4.81)
Brand notoriety: FBIOP and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 47% vs. VNDA: 146%
Market capitalization -- FBIOP: $0 vs. VNDA: $312.59M
FBIOP [@Biotechnology] is valued at $0. VNDA’s [@Biotechnology] market capitalization is $312.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green while VNDA’s FA Score has 1 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, FBIOP is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 3 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • FBIOP’s TA Score: 3 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FBIOP is a better buy in the short-term than VNDA.

Price Growth

FBIOP (@Biotechnology) experienced а -4.55% price change this week, while VNDA (@Biotechnology) price change was -3.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

VNDA is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
FBIOP
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
WIN.X0.0000500.000002
+4.68%
WINkLink cryptocurrency
AR.X4.2947760.188316
+4.59%
Arweave cryptocurrency
EOT15.450.09
+0.59%
EATON VANCE NATIONAL Municipal OPPORTUNITIES TRUST
OWNB22.710.02
+0.10%
Bitwise Bitcoin Standard Corporations ETF
ICPY12.92-0.06
-0.49%
Tweedy, Browne International Insider + Value ETF (ICPY)

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been loosely correlated with FBIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIOP jumps, then FBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
-2.73%
FBIO - FBIOP
35%
Loosely correlated
-3.27%
RADX - FBIOP
29%
Poorly correlated
-8.64%
VNDA - FBIOP
26%
Poorly correlated
-2.04%
EVGN - FBIOP
26%
Poorly correlated
+9.70%
NKTR - FBIOP
25%
Poorly correlated
-22.39%
More